Kaposi’s sarcoma regression after long term treatment of m-TOR inhibitors and cancellation of immunosuppressive therapy in patient after kidney transplantation
Open Access
- 12 July 2019
- journal article
- research article
- Published by V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs in Russian Journal of Transplantology and Artificial Organs
- Vol. 21 (2), 121-124
- https://doi.org/10.15825/1995-1191-2019-2-121-124
Abstract
A case of observation of a patient who developed Kaposi's sarcoma after kidney transplantation is presented. For the purpose of its treatment, conversion from tacrolimus to everolimus, courses of administration of prospidin were applied, in General, the intensity of immunosuppressive therapy was reduced. Stable remission was achieved only after removal of the renal transplant and complete withdrawal of immunosuppressive therapy.Keywords
This publication has 7 references indexed in Scilit:
- Risk of Kaposi sarcoma after solid organ transplantation in the United StatesInternational Journal of Cancer, 2018
- Eyelid Kaposi Sarcoma in an HIV-negative PatientIndian Journal of Ophthalmology, 2018
- Outcome of second kidney transplantation in patients with previous post‐transplantation Kaposi's sarcoma: A French retrospective studyClinical Transplantation, 2017
- The Effect of Conversion from a Calcineurin Inhibitor to Sirolimus on Skin Cancer Reduction in Post-renal Transplantation PatientsCureus, 2017
- Post kidney transplantation Kaposi's sarcoma: the experience of a Mediterranean North African centerClinical Transplantation, 2016
- Pulmonary Kaposi's sarcoma after heart transplantation: a case reportJournal of Medical Case Reports, 2010
- Kaposi's sarcoma in kidney transplant recipients: a 23-year experienceQJM: An International Journal of Medicine, 2005